|
Ireland to Look at Cost-Effectiveness in Assessing Healthcare Technologies
Devicemakers are taking a wait-and-see attitude toward Ireland’s new guidelines on weighing the cost of healthcare technologies.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Related Articles
IMDRF Unveils Global UDI Scheme; Core Concepts Endorsed in EU RecommendationMTAA Seeks Specific Language on Medical Apps in Australian Mobile Privacy GuidelineMTAA Seeks Specific Language on Medical Apps in Australian Mobile Privacy GuidelineChina Considering Fast-Track Pathway for Novel Medical Technologies
|
Subscribe
Archives